8918
C. G. Francisco et al. / Tetrahedron 63 (2007) 8910–8920
10.0 Hz); 13C NMR 22.6 (CH3), 23.3 (CH2), 55.9 (CH2),
58.1 (CH3), 58.4 (CH3), 61.6 (CH3), 66.3 (CH), 77 (CH),
79 (CH), 80.2 (CH), 99.5 (C); MS (EI) m/z (rel intensity)
231 (M+, <1), 203 (4), 187 (4); HRMS calcd for
C11H19O5 231.1232, found 231.1291. Anal. Calcd for
C11H20O5: C, 56.88; H, 8.68. Found: C, 56.54; H, 9.02.
217 (<1), 201 (2); HRMS calcd for C11H20O5 232.1310,
found 232.1334. Anal. Calcd for C11H20O5: C, 56.88; H,
8.68. Found: C, 56.87; H, 8.58. Compound 31: colourless
oil; [a]D ꢀ8.4 (c, 0.55); IR 2934, 2827, 1446, 1103,
1
1050 cmꢀ1; H NMR 1.29 (3H, d, J¼6.7 Hz), 1.89 (1H,
m), 2.35 (1H, m), 3.07 (1H, dd, J¼2.4, 6.2 Hz), 3.26 (3H,
s), 3.45 (3H, m), 3.52 (3H, s), 3.61 (1H, d, J¼2.4 Hz),
3.66 (1H, dq, J¼6.2, 6.7 Hz), 3.82 (1H, ddd, J¼6.4, 8.8,
8.8 Hz), 4.11 (1H, ddd, J¼5.5, 8.8, 8.8 Hz), 4.21 (1H, dd,
J¼1.7, 6.9 Hz); 13C NMR 18.6 (CH3), 31.4 (CH2), 48.5
(CH3), 57.9 (CH3), 58.1 (CH3), 66.4 (CH2), 68.7 (CH),
76.7 (2ꢂCH); MS (EI) m/z (rel intensity) 232 (M+, 16),
217 (1), 201 (4), 185 (2), 169 (2); HRMS calcd for
C11H20O5 232.1310, found 232.1282. Anal. Calcd for
C11H20O5: C, 56.88; H, 8.68. Found: C, 57.08; H, 8.32.
4.3.4. Methyl 3,7-anhydro-2-deoxy-5,6,8-tri-O-methyl-a-
D-manno-oct-4-ulofuranoside (29). Following the general
procedure, precursor 13 (249 mg, 0.942 mmol) afforded
the anhydrosugar 29 (174 mg, 0.66 mmol, 70%) as a colour-
less oil: [a]D +13.3 (c, 0.42); IR 2933, 2828, 1740, 1456,
1
1194, 1106 cmꢀ1; H NMR 1.87 (1H, m), 2.27 (1H, m),
3.17 (1H, dd, J¼2.6, 6.9 Hz), 3.19 (3H, s), 3.30 (3H, s),
3.36 (3H, s), 3.42 (1H, dd, J¼3.3, 10.4 Hz), 3.45 (3H, s),
3.52 (1H, dd, J¼7.2, 10.4 Hz), 3.54 (1H, d, J¼2.6 Hz),
3.65 (1H, ddd, J¼3.4, 6.9, 6.9 Hz), 3.75 (1H, ddd, J¼6.4,
8.8, 8.8 Hz), 4.05 (1H, ddd, J¼5.8, 8.7, 8.7 Hz), 4.16 (1H,
br d, J¼5.6 Hz); 13C NMR 31.3 (CH2), 48.4 (CH3), 57.8
(CH3), 58.1 (CH3), 59.1 (CH3), 66.4 (CH2), 72.1 (CH2),
72.3 (CH), 76.5 (CH), 76.9 (CH), 77.2 (CH), 105.1 (C);
MS (EI) m/z (rel intensity) 262 (M+, 17), 231 (1), 217
(23); HRMS calcd for C12H22O6 262.1416, found
262.1379. Anal. Calcd for C12H22O6: C, 54.95; H, 8.45.
Found: C, 55.27; H, 8.10.
4.3.7. Formation of compounds 31, 35 and 3-acetyl-2,8-
anhydro-1,7-didesoxy-3,4,5-tri-O-methyl-L-arabino-
octo-2,5-diulo-2,6-pyranose (36). Following the general
procedure for IHA reactions adding NaHCO3 (100%) to
the reaction mixture, precursor 8 (360 mg, 1.53 mmol) af-
forded anhydrosugars 35 (50 mg, 0.215 mmol, 14%), 31
(130 mg, 0.56 mmol, 37%) and 36 (20 mg, 0.07 mmol,
4.5%). Compound 36: [a]D +11.1 (c, 0.28); IR 2943, 2747,
1
1222, 1112 cmꢀ1; H NMR 1.35 (3H, s), 1.77 (1H, dddd,
J¼3.7, 6.8, 10.6, 14.2 Hz), 1.99 (1H, dddd, J¼2.8, 4.0,
10.5, 14.0 Hz), 2.10 (3H, s), 3.08 (1H, d, J¼8.9 Hz), 3.59
(3H, s), 3.62 (3H, s), 3.66 (3H, s), 3.72 (1H, ddd, J¼2.5,
6.7, 11.2 Hz), 3.82 (1H, ddd, J¼4.4, 10.8, 10.8 Hz), 3.85
(1H, d, J¼8.9 Hz), 5.21 (1H, dd, J¼3.8, 10.6 Hz), 13C
NMR 21.8 (CH3), 22.7 (CH3), 24.5 (CH2), 53.3 (CH3),
56.0 (CH2), 61.6 (CH3), 61.8 (CH3), 67.1 (CH), 83.3 (CH),
84.4 (CH), 98.5 (C), 105.0 (C), 169.6 (C); MS (EI) m/z
(rel intensity) 290 (M+, 3), 259 (7), 231 (6), 199 (8);
HRMS calcd for C13H22O7 290.1365, found 290.1314.
Anal. Calcd for C13H22O7: C, 53.78; H, 7.64. Found: C,
53.80; H, 7.39.
4.3.5. 1,3,4,5-Tetra-O-acetyl-2,8-anhydro-7-deoxy-b-
D-altro-oct-2-ulopyranose (30). Following the general
procedure, precursor 10 (75 mg, 0.2 mmol) afforded the an-
hydrosugar 30 (36 mg, 0.096 mmol, 48%) as a colourless
oil: [a]D ꢀ36.9 (c, 0.36); IR 2966, 1747, 1434, 1372,
1
1225, 1056 cmꢀ1; H NMR 1.97 (1H, m), 1.99 (3H, s),
2.07 (3H, s), 2.08 (1H, m), 2.11 (3H, s), 2.16 (3H, s), 3.92
(1H, ddd, J¼2.7, 10.8, 10.8 Hz), 3.93 (1H, d, J¼12.0 Hz),
3.98 (1H, ddd, J¼4.7, 11.2, 11.2 Hz), 4.17 (1H, d,
J¼12.0 Hz), 4.36 (1H, ddd, J¼2.0, 3.7, 11.1 Hz), 5.25
(1H, dd, J¼2.1, 3.9 Hz), 5.38 (1H, d, J¼10.3 Hz), 5.66
(1H, dd, J¼3.9, 10.3 Hz); 13C NMR 20.6 (2ꢂCH3), 20.7
(CH3), 20.9 (CH3), 26.1 (CH2), 57.7 (CH2), 63.4 (CH2),
67.2 (CH), 67.8 (CH), 69.6 (CH), 71.9 (CH), 97.7 (C),
169.8 (C), 170.1 (C), 170.3 (C), 170.5 (C); MS (EI) m/z
(rel intensity) 375 (M++H, 1), 331 (2), 315 (14); HRMS
calcd for C16H23O10 375.1291, found 375.1266. Anal. Calcd
for C16H22O10: C, 51.33; H, 5.92. Found: C, 51.48; H, 6.11.
4.3.8. 3,4,5-Tri-O-acetyl-2,8-anhydro-1,7-dideoxy-b-L-
altro-oct-2-ulopyranose (32). Following the general pro-
cedure, precursor 6 (52 mg, 0.163 mmol) afforded the
anhydrosugar 32 (27 mg, 0.085 mmol, 53%) as a colourless
oil: [a]D +65 (c, 0.36); IR 2972, 2747, 1372, 1226,
1059 cmꢀ1; 1H NMR 1.31 (3H, s), 1.87 (1H, m), 1.98 (3H,
s), 2.09 (3H, s), 2.11 (1H, m), 2.14 (3H, s), 3.83–3.94 (2H,
m), 4.25 (1H, ddd, J¼2.2, 2.2, 10.8 Hz), 5.21 (1H, d,
J¼9.9 Hz), 5.23 (1H, dd, J¼1.9, 3.9 Hz), 5.63 (1H, dd,
J¼3.9, 9.9 Hz); 13C NMR 20.6 (CH3), 20.8 (CH3), 20.9
(CH3), 22.9 (CH3), 26 (CH2), 56.8 (CH2), 67.4 (CH), 69.4
(CH), 71.7 (CH), 72.2 (CH), 98.7 (C), 170.1 (C), 170.2
(C), 170.5 (C); MS (EI) m/z (rel intensity) 316 (M+, 7),
273 (1), 257 (10), 197 (7), 155 (25); HRMS calcd for
C14H20O8 316.1158, found 316.1189. Anal. Calcd for
C14H20O8: C, 53.16; H, 6.37. Found: C, 53.23; H, 6.10.
4.3.6. Methyl 3,7-anhydro-2,8-dideoxy-5,6-di-O-methyl-
a-L-manno-oct-4-ulofuranoside (31) and 2,8-anhydro-
1,7-dideoxy-3,4,5-tri-O-methyl-b-L-altro-oct-2-ulopyra-
nose (35). Following the general procedure, precursor 8
(63 mg, 0.269 mmol) afforded the anhydrosugar 35 (7 mg,
0.03 mmol, 11%), and anhydrosugar 31 (28 mg,
0.12 mmol, 44.5%). Compound 35: crystalline compound,
mp 80.5–82.5 ꢁC; [a]D +97.8 (c, 0.45); IR 2940, 2885,
1
2831, 1469, 1378, 1119, 1064 cmꢀ1; H NMR 1.37 (3H,
s), 1.58 (1H, dddd, J¼3.5, 6.8, 10.3, 13.7 Hz), 2.04 (1H,
dddd, J¼2.7, 4.8, 10.8, 13.5 Hz), 3.25 (1H, d, J¼9.2 Hz),
3.43 (1H, dd, J¼2.1, 3.8 Hz), 3.48 (3H, s), 3.51 (3H, s),
3.58 (3H, s), 3.74 (1H, ddd, J¼2.7, 6.7, 11.2 Hz), 3.87
(1H, dd, J¼3.8, 9.2 Hz), 3.90 (1H, ddd, J¼4.7, 11.0,
11.0 Hz), 4.36 (1H, ddd, J¼1.9, 3.6, 10.8 Hz); 13C NMR
23.0 (CH3), 25.7 (CH2), 56.5 (CH2), 57.9 (CH3), 58.1
(CH3), 61.4 (CH3), 66.9 (CH), 78.7 (CH), 80.1 (CH), 82.7
(CH), 99.2 (C); MS (EI) m/z (rel intensity) 232 (M+, <1),
4.3.9. (2R)-2,8-Anhydro-5,7-dideoxy-1,3,4-tri-O-methyl-
D-arabino-oct-2-ulopyranose (33). Following the general
procedure, precursor 17 (140 mg, 0.60 mmol) afforded the
cyclised compound 33 (88.3 mg, 0.38 mmol, 64%) as a col-
ourless oil: [a]D ꢀ3.3 (c, 0.09); IR 2931, 2830, 1731, 1450,
1
1260, 1195, 1113 cmꢀ1; H NMR 1.62 (1H, m), 1.83 (1H,
m), 2.04 (1H, m), 2.17 (1H, m), 3.29–3.37 (2H, m), 3.39
(3H, s), 3.45 (1H, m), 3.45 (3H, s), 3.55 (3H, s), 3.75–3.86